Annual Accounts Payable
N/A
December 31, 2023
Summary
- APVO annual accounts payable is not available.
Performance
APVO Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Payable
$3.53 M
-$204.00 K-5.46%
September 30, 2024
Summary
- As of February 8, 2025, APVO quarterly accounts payable is $3.53 million, with the most recent change of -$204.00 thousand (-5.46%) on September 30, 2024.
- APVO quarterly accounts payable is now -71.04% below its all-time high of $12.20 million, reached on March 31, 2016.
Performance
APVO Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
APVO Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
APVO Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -11.7% | +8.9% | ||
| 5 y | 5-year | -29.4% | +8.9% | ||
| alltime | all time | -71.0% | +8.9% |
Aptevo Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.53 M(-5.5%) |
| Jun 2024 | - | $3.74 M(+0.4%) |
| Mar 2024 | - | $3.72 M(-7.0%) |
| Sep 2023 | - | $4.00 M(+23.3%) |
| Sep 2022 | - | $3.24 M(-0.8%) |
| Jun 2022 | - | $3.27 M(-16.4%) |
| Mar 2022 | - | $3.91 M(-16.1%) |
| Jun 2020 | - | $4.66 M(-6.8%) |
| Mar 2020 | - | $5.00 M(-58.6%) |
| Sep 2019 | - | $12.07 M(+1.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $11.90 M(+7.8%) |
| Mar 2019 | - | $11.04 M(-5.4%) |
| Dec 2018 | $11.67 M(+58.8%) | $11.67 M(+19.0%) |
| Sep 2018 | - | $9.81 M(+2.9%) |
| Jun 2018 | - | $9.54 M(+31.3%) |
| Mar 2018 | - | $7.26 M(-1.2%) |
| Dec 2017 | $7.35 M(-35.9%) | $7.35 M(-34.3%) |
| Jun 2016 | - | $11.19 M(-8.2%) |
| Mar 2016 | - | $12.20 M(+21.0%) |
| Dec 2015 | - | $10.08 M |
| Dec 2014 | $11.47 M | - |
FAQ
- What is the all time high annual accounts payable for Aptevo Therapeutics?
- What is Aptevo Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Aptevo Therapeutics?
What is the all time high annual accounts payable for Aptevo Therapeutics?
Aptevo Therapeutics all-time high annual accounts payable is $11.67 M
What is Aptevo Therapeutics quarterly accounts payable?
The current quarterly accounts payable of APVO is $3.53 M
What is the all time high quarterly accounts payable for Aptevo Therapeutics?
Aptevo Therapeutics all-time high quarterly accounts payable is $12.20 M